Back
CI Bio-Revolution Idx ETF Vs. Kymera Therapeutics Industry Stock Comparison
Buy
55
CDNA.TO
CI Bio-Revolution Idx ETF
Last Price:
17.73
Seasonality Move:
-8.88%
Buy
73
KYMR
Kymera Therapeutics
Last Price:
48.52
Seasonality Move:
1.07%
Buy
55
CI Bio-Revolution Idx ETF (CDNA.TO)
is a Buy
Is CI Bio-Revolution Idx ETF a Buy, Sell or Hold?
- The current CI Bio-Revolution Idx ETF [CDNA.TO] share price is $17.73. The Score for CDNA.TO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CDNA.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.50. The Score for KYMR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CDNA.TO Stock Price Chart
What is CI Bio-Revolution Idx ETF's stock price today?
-
The CI Bio-Revolution Idx ETF share price today is $17.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDNA.TO is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
CDNA.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 94.34 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.54 - 17.8) | Buy |
| Bollinger Bands (100): | (15.69 - 17.39) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.34 | Buy |
| Relative Strength Index (14 RSI): | 62.83 | Buy |
| Chaikin Money Flow: | 417171 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.57 - 45.01) | Buy |
| Bollinger Bands (100): | (32.37 - 41.77) | Buy |
CDNA.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.73 | Sell |
| 20-day SMA: | 17.71 | Buy |
| 50-day SMA: | 17 | Buy |
| 200-day SMA: | 16.67 | Buy |
| 8-day EMA: | 17.73 | Buy |
| 20-day EMA: | 17.61 | Buy |
| 50-day EMA: | 17.19 | Buy |
| 200-day EMA: | 16.91 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.55 | Buy |
| 20-day SMA: | 43.13 | Buy |
| 50-day SMA: | 38.73 | Buy |
| 200-day SMA: | 33.41 | Buy |
| 8-day EMA: | 44.01 | Buy |
| 20-day EMA: | 42.81 | Buy |
| 50-day EMA: | 40.25 | Buy |
| 200-day EMA: | 34.43 | Buy |
CI Bio-Revolution Idx ETF Earnings Growth & CDNA.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.38 per share.
CI Bio-Revolution Idx ETF Technical Analysis
| Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||